Senior experienced biotechnology leader in innovative, startup-like environments. Accustomed to managing small teams in genomics and epigenetics; Completely independent investigator from design to benchwork to data. Interested in development and commercialization of novel NGS diagnostic assays, tools, and technologies for both clinical and veterinary applications.Contributed to: Aging and longevity (skeletal muscle stem cells in mouse models, DNA methylation~ age associations), EWAS studies (validation of targets associated with blood lipid traits), Animal models of hemostasis and thrombosis, Methylation arrays, characterization of colorectal cancer (WES, RNA-seq, Imaging mass cytometry panel dev), Copy number variation associations with disease, Characterization of methylation in autoimmune disease, Epigenetic programs of the CD4 locus in mouse models, liquid biopsy assay development (fragment, methylation), deconvolution (DNAMe based digital histology).Contributed to early launch of 4 startups in NGS genomics:1. Ubiquity Genomics (now part of BioDynami): custom targeted hybridization capture based sequencing using the CATCH-Seq platform for clinically relevant targets for validation and research; MHC-seq and KIR/LRC loci https://biodynami.com/targeted-sequencing/#targeted-sequencing-listing2. BioDynami: affordable NGS library prep tools and kits, novel bead based systems for automated library prep an extraction, nucleic acid quant, MSB-Seq platform, CATCH-seq https://biodynami.com/3. IMIDomics: multiomics profiling of all immune mediate inflammatory diseases, proprietary database of autoimmune data https://www.imidomics.com/about4. Vidium Animal Health: precision oncology in canine; multi-cancer early detection from plasma25 years of biotechnology experience, 15 years of genomics and NGS > Methylation, Cancer MCED Targeted, solution-hyb based sequencing, bisulfite and oxidative bisulfite, data processing and bioinformatics Trained in zebrafish, chick, and mouse models Interests:> Age-related DNA methylation changes, Tet-mediated demethylation mechanisms> Dev of reduced costs in targeted capture tools for NGS and high density methylation profiling> Molecular and cellular characterization of colorectal cancer for precision oncology, detection> cfDNA epigenetic assay development> T cell molecular profiling and tumor infiltration> autoimmunity> epigenetic associations and gene expression> Integration of multiple omic datasets for personalized medicine approaches, ML models